Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris

Clinical trial NCT00287547 · COMPLETED

Trial details

NCT number: NCT00287547
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 1997-03-01
Primary completion: 1998-01-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.